Syndicate This week's upcoming IPO's and secondary offerings

Week of August 7 to August 11, 2024

This Week's Deals to be Priced

08/09 - Wednesday

Symbol

Issuer

Type

Price

Managers

CTRA

Contura Energy
Contura Energy
IPO
Postponed $23.00-27.00
6M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Jefferies, Credit Suisse & UBS, Citi, Jefferies, Barclays, BMO Capital, Clarksons Platou, FBRC, GHSC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MOD

Modine Manufacturing
Modine Manufacturing
Spot Secondary
Cancelled $15.50-15.75
5M
Baird,...

Pricing after close

Managers: Baird, KeyBanc, GHSC, Craig-Hallum

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

08/07 - Monday

Symbol

Issuer

Type

Price

Managers

BIOA

BioAmber
BioAmber
Spot Secondary
Priced: $.75
14.667M
Rodman & Renshaw

Pricing after close

Managers: Rodman & Renshaw

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
COTV

Cotiviti Holdings
Cotiviti Holdings
Spot Secondary
Priced: $37.00
10M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Baird, William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ESNT

Essent Group
Essent Group
Spot Secondary
Priced: $39.90
5M
Barclays

Pricing after close
Deal analysis and details

Managers: Barclays

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

08/08 - Tuesday

Symbol

Issuer

Type

Price

Managers

EVH

Evolent Health
Evolent Health
Secondary
Priced: $19.85
8.816M
JPMorgan & Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan & Goldman Sachs, Wells Fargo, William Blair, Truist, Leerink, Baird

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MKC

McCormick
McCormick
Secondary
Priced: $90.50
5.525M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, Credit Suisse, Truist & Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MYOK

MyoKardia
MyoKardia
Secondary
Priced: $35.50
3.5M
JPMorgan & TD Cowen,...

Pricing after close
Deal analysis and details

Managers: JPMorgan & TD Cowen, BMO Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TMO

Thermo Fisher
Thermo Fisher
Secondary
Priced: $171.00
8.772M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, BofA, Citi

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VUZI

Vuzix
Vuzix
Secondary
Priced: $5.75
1.5M
Chardan,...

Pricing after close

Managers: Chardan, MXIM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ZEAL

Zealand Pharma
Zealand Pharma
Secondary
Priced: $17.87
4.375M
Morgan Stanley & Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & Goldman Sachs, Guggenheim, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ED

Consolidated Edison
Consolidated Edison
Spot Secondary
Priced: $83.95
4.1M
JPMorgan

Pricing after close

Managers: JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
H

Hyatt
Hyatt
Spot Secondary
Priced: $58.00
8.654M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HR

Healthcare Realty Trust
Healthcare Realty Trust
Spot Secondary
Priced: $30.90
7.25M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Barclays & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LOB

Live Oak Bancshares
Live Oak Bancshares
Spot Secondary
Priced: $23.00
4.5M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Sandler O'Neill, Truist

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MBUU

Malibu Boats
Malibu Boats
Spot Secondary
Priced: $25.25
2M
Raymond James,...

Pricing after close
Deal analysis and details

Managers: Raymond James, Truist & Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PRAH

PRA Health
PRA Health
Spot Secondary
Priced: $75.75
10M
Morgan Stanley & Wells Fargo

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

08/09 - Wednesday

Symbol

Issuer

Type

Price

Managers

DVAX

Dynavax
Dynavax
Secondary
Priced: $15.00
5M
TD Cowen,...

Pricing after close
Deal analysis and details

Managers: TD Cowen, RBC Capital & William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ESPR

Esperion
Esperion
Secondary
Priced: $49.00
3.1M
Jefferies,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Jefferies, TD Cowen & UBS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MVIS

MicroVision
MicroVision
Secondary
Priced: $2.10
4.762M
Ladenburg,...

Pricing after close

Managers: Ladenburg, RODR

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FANG

Diamondback Energy
Diamondback Energy
Spot Secondary
Priced: $92.60
3M
Credit Suisse

Pricing after close
Deal analysis and details

Managers: Credit Suisse

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MANU

Manchester United
Manchester United
Spot Secondary
Priced: $17.00
4.25M
Morgan Stanley

Pricing after close

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MCRN

Milacron
Milacron
Spot Secondary
Priced: $17.00
9M
Credit Suisse

Pricing after close
Deal analysis and details

Managers: Credit Suisse

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MX

MagnaChip
MagnaChip
Spot Secondary
Priced: $11.10
4.01M
Barclays

Pricing after close
Deal analysis and details

Managers: Barclays

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

08/10 - Thursday

Symbol

Issuer

Type

Price

Managers

ACRS

Aclaris Therapeutics
Aclaris Therapeutics
Block Trade
Priced: $23.02
3.26M
Jefferies & Leerink,...

Pricing after close
Deal analysis and details

Managers: Jefferies & Leerink, William Blair, Guggenheim, JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RNGR

Ranger Energy
Ranger Energy
IPO
Priced: $14.50
5.82M
Credit Suisse,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Credit Suisse, Simmons, Wells Fargo, Barclays, Evercore ISI

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
YOGA

YogaWorks
YogaWorks
IPO
Priced: $5.50
7.3M
TD Cowen,...

Pricing after close
Deal analysis and details

Managers: TD Cowen, Stephens & Guggenheim, Roth MKM, Imperial Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BGNE

BeiGene
BeiGene
Secondary
Priced: $71.00
2.465M
Morgan Stanley & Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & Goldman Sachs, TD Cowen, Baird, William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KURA

Kura Oncology
Kura Oncology
Secondary
Priced: $6.50
7.7M
Leerink & TD Cowen,...

Pricing after close
Deal analysis and details

Managers: Leerink & TD Cowen, JMP Securities, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NCLH

Norwegian Cruise Line
Norwegian Cruise Line
Spot Secondary
Priced: $54.75
15M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Barclays & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access